ORIGINAL RESEARCH article
Front. Nutr.
Sec. Clinical Nutrition
Volume 12 - 2025 | doi: 10.3389/fnut.2025.1601446
This article is part of the Research TopicKetogenic Metabolic Therapies in Prevention & Treatment of Non-communicable DiseasesView all 18 articles
A Mixed Methods Feasibility Study of a Ketogenic Diet as Treatment for Parkinson's
Provisionally accepted- 1Helfgott Research Institute, National University of Natural Medicine, Portland, Oregon, United States
- 2Colorado State University, Fort Collins, Colorado, United States
- 3Sonoran University of Health Sciences, Tempe, Arizona, United States
- 4School of Pharmacy, Pacific University, Hillsboro, United States
Select one of your emails
You have multiple emails registered with Frontiers:
Notify me on publication
Please enter your email address:
If you already have an account, please login
You don't have a Frontiers account ? You can register here
Objective: People with Parkinson's disease (PD) have been shown to benefit from a ketogenic diet (KD). However, evidence suggests the traditional KD's high dairy consumption may exacerbate PD symptoms. This patient-initiated study assessed the feasibility and acceptability of a novel ketogenic diet limiting dairy products in patients with PD. Quality of life and functional movements were also evaluated.Methods: Twelve people with PD followed a modified, low dairy KD for 12 weeks. We provided support and nutritional education to assist with adherence. Subjects recorded daily food diaries, from which total macronutrients were calculated. Every 4 weeks blood (complete blood count (CBC), lipid panel, vitamin D, beta-hydroxybutyrate, electrolytes), urinalysis (calcium, creatinine), vitals, height, weight, quality of life (Parkinson's Disease Questionnaire-39 (PDQ-39)) and functional movement assessments (Unified Parkinson's Disease Rating Scale (UPDRS), Freezing of Gait, mini-Balance Evaluation Systems Test (mini-BEST), 360° Turn) were collected.All subjects completed the study and 75% recorded at least three-quarters of their daily food diary entries. Average macronutrient levels (70% fat, 18% protein, 5% net carbohydrate) and beta-hydroxybutyrate levels (p<0.005) confirmed nutritional ketosis was maintained. Clinical improvements were found in total UPDRS, UPDRS Part III, miniBEST, Freezing of Gait, and quality of life. All participants lost weight; 58% reported no change in constipation and 8% reported improvement.This exploratory study deemed the modified ketogenic diet feasible and acceptable. Findings suggest a low dairy KD may provide similar benefits to a traditional KD for those with PD, while reducing potential risks associated with consuming higher amounts of animal dairy products.
Keywords: Ketogenic Diet, Parkinson's disease, Patient-initiated, gut microbiome, Inflammation, Glucose
Received: 27 Mar 2025; Accepted: 30 Jun 2025.
Copyright: © 2025 Worster, Colgan, Vita, McClure, Buttolph, Hodges, Senders, Erlandsen, Elbarbry and Zwickey. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
* Correspondence: Kate Worster, Helfgott Research Institute, National University of Natural Medicine, Portland, 97201, Oregon, United States
Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.